BioSpace News Archive

Growing prevalence of chronic obstructive pulmonary disease (COPD) and congenital heart disease (CHD) and technological advancements in pulse oximeter devices are among the key factors driving the global market revenue growth.

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the fourth quarter 2021 and corporate updates, before market open on Tuesday, March 8, 2022.

Blueprint Medicines Corporation announced that, effective on March 1, 2022, the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 12,591 shares of its common stock and an aggregate of 6,293 restricted stock units to twelve new employees under Blueprint Medicines’ 2020 Inducement Plan.

Biosensors are endogenous compounds, are used to monitor cell cultures. Cell cultures are used for several purposes such as for understanding biological mechanisms in the field of regenerative medicines and in development of new drugs and therapies.

Albany NY, United States: Fibrous cortical is chronic bone disorder typical occur in children usually between 2-12 years of age.

Notable rise in the number of cancer patients globally is boosting the sales prospects in the gamma probe device market.

Researchers from the Minds Matter Concussion Program and the Center for Violence Prevention at Children’s Hospital of Philadelphia have identified important differences in the initial evaluation and outcomes between patients who suffered a concussion as the result of assault compared with those who suffered a concussion sustained during sports.

TeleVet, Inc. and Boehringer Ingelheim Animal Health USA Inc. announced a strategic collaboration to deliver innovative technology and services that will make it easier for veterinary practices to provide the best patient care while alleviating stress on their teams.

Increasing prevalence of chronic and acute diseases across the globe and rise in government and private investments in healthcare infrastructure development are among the key factors driving the global market revenue growth.

Increasing demand for personalized medicines, improving healthcare and research infrastructure, and rising awareness about cell culture based products are some key factors expected to drive market revenue growth.